Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Giving drugs, such as docetaxel, directly into the pleura after surgery to drain
the pleural effusion may help keep fluid from building up again.
PURPOSE: This phase I trial is studying the side effects, best way to give, and best dose of
intrapleural docetaxel given after surgery in patients with malignant pleural effusion.